| Nov 12 |
iBio GAAP EPS of -$0.46 in-line
|
| Nov 12 |
iBio Reports Fiscal First Quarter 2025 Financial Results
|
| Oct 10 |
iBio and AstralBio Provide Update on Myostatin Program for Obesity
|
| Sep 23 |
AAR, ShiftPixy And 3 Stocks To Watch Heading Into Monday
|
| Sep 20 |
iBio GAAP EPS of -$4.03, revenue of $0.23M beats by $0.2M
|
| Sep 20 |
iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
|
| Sep 3 |
iBio to Participate in Upcoming Investor Conferences
|
| Aug 12 |
iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development
|
| Jul 5 |
iBio files $150M mixed shelf offering
|
| Jun 3 |
iBio Closes Sale of Manufacturing Facility in Texas
|
